Physician profile
Amanda J Bissell
NPI 1336145481
$4,310.15
in general payments reported to CMS, 2019-2025
15 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $57.42 · 2021: $442 · 2022: $261 · 2023: $303 · 2024: $2,860 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $890 · Travel and Lodging: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $889.62 |
| Travel and Lodging | $455.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,653.25 | 2021-2024 | Synergeyes Contact Lens, Cvi Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $347.61 | 2019-2025 | Precision 1, Eysuvis, Total30 |
| Allergan, INC. | $313.64 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $223.10 | 2022-2024 | Infuse, Xiidra, Miebo |
| Sun Pharmaceutical Industries INC. | $197.95 | 2019-2025 | Cequa, Xelpros |
| Amgen INC. | $149.99 | 2025 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $130.59 | 2024 | Tecnis Simplicity |
| Abbvie INC. | $121.48 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $42.62 | 2020-2021 | |
| Sight Sciences, INC. | $30.88 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.51 | 2020 | |
| Servier Pharmaceuticals LLC | $22.11 | 2024 | |
| Synergeyes, INC. | $19.50 | 2021 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Shire North American Group INC | $15.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bissell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.